Bonnell Aluminum Commences Production with New Extrusion Line

Bonnell Aluminum, a subsidiary of Tredegar Corporation, announced today that its new extrusion line has begun production, and the volume ramp-up is progressing as planned.

“We are excited about our early entry to the automotive industry, at a time when fuel efficiency standards are driving growth in aluminum content in vehicles,” said Brook Hamilton, President of Bonnell Aluminum. He added, “With our state-of-the-art equipment, outstanding technical resources, and registered automotive quality management system, we believe we have positioned Bonnell as a premier supplier in this growing market.”

Early last year, the Company announced it was investing approximately $17 million in an expansion project at its Newnan, Georgia facility. This project includes the addition of a new 9”–3,600 ton state-of-the-art aluminum extrusion press fully dedicated to serving the growing demand for aluminum extruded components from automotive and light truck original equipment manufacturers.

The Company previously announced in July 2013 that it had achieved ISO/TS 16949 registration from the International Organization for Standardization / Technical Specification. This technical specification aligns global automotive quality systems standards and fosters the development of a quality management system for use in the automotive supply chain.

About Bonnell Aluminum

Bonnell Aluminum is a subsidiary of Richmond, VA, based Tredegar Corporation. (NYSE:TG). The company produces soft and medium-strength alloy aluminum extrusions for building and construction, machinery and equipment, consumer durables, transportation, electrical and distribution markets.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.